Oasmia postpones the release of the Q4 and year-end report to 28 June

World News: . []

“Due to outstanding issues in the review, and also to make sure that fact-based decisions can be made, the Board has decided to postpone the release of the year-end report,” says , Chairman of Oasmia.

The ongoing review includes both valuation issues in the balance sheet as well as strategic planning discussions. The latter are conducted in co-operation with former Chairman of the Board and the CFO.

The outcome of the review and initiatives initiated by Oasmia’s new Board will communicated to the market as soon as there is relevant information to be shared. 

For further information, please contact IR@Oasmia.com

Information is also available at www.oasmia.com www.nasdaqomxnordic.com www.boerse-frankfurt.de twitter.com/oasmia

More news and information about Oasmia Pharmaceutical AB

Published By:

Globe Newswire: 07:00 GMT Wednesday 15th May 2019

Published: .

Search for other references to "oasmia" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
Privacy Policy | Terms and Conditions | Contact Us